Unlock instant, AI-driven research and patent intelligence for your innovation.

Peptide with permeable cell membrane or body tissue barrier functions and application of peptide

A cell membrane and barrier technology, applied in the field of biopharmaceuticals, can solve the problems of high cytotoxicity and low transfer efficiency

Active Publication Date: 2017-09-05
SHANGHAI FIRST PEOPLES HOSPITAL
View PDF3 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, studies have pointed out that the use of recombinant viruses to deliver deoxyribonucleic acid (deoxyribonucleic acid, DNA) expression cassettes into the eye, while overexpressing therapeutic gene products in the eye, is likely to do more harm than good, and its existence is very large. limitations, such as low transfer efficiency, high cytotoxicity, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Peptide with permeable cell membrane or body tissue barrier functions and application of peptide
  • Peptide with permeable cell membrane or body tissue barrier functions and application of peptide
  • Peptide with permeable cell membrane or body tissue barrier functions and application of peptide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0078] As an embodiment of the present invention, the functional molecule is a preparation with the function of molecular packaging and loading, including but not limited to liposomes, polymers, dendritic molecules, nano-packaging preparations and the like.

[0079] As an embodiment of the present invention, the functional molecule is a viral vector capable of carrying genetic material, including but not limited to a retroviral vector, a lentiviral vector, or an adenoviral vector.

[0080] The connection method between the membrane-penetrating peptide and the functional molecule of the present invention can be covalent connection or non-covalent connection. It should be understood that as long as the functions of membrane-penetrating peptides and functional molecules can be retained, and the effect of penetrating cell membranes and body tissue barriers can be preserved, any connection method can be included in the present invention. Covalent linking usually links two molecules...

Embodiment 1

[0110] Example 1. In vivo directed evolution screening of eye guide peptides

[0111] The present inventors used phage display technology to enrich specific recombinant phages from various variants (peptide library, peptide library) of recombinant phages purposefully by using phage display technology in vivo directed evolution method, and through sequencing analysis, combining the enrichment effect and the Based on the affinity of retinal target tissue, the dominant recombinant phage peptides with the potential to penetrate the eye barrier were screened out.

[0112] In this embodiment, Ph.D. TM The system (M13KE), which is based on the M13 single-chain phage vector (M13mp19), introduces a recombination site at the 5' end of its gene gIII, thereby fusing and recombining the N-terminal of a polypeptide consisting of 12 amino acid residues into the phage minor capsid protein pIII. Each recombinant phage displayed 5 single-cloned polypeptides, and recombinant phages displaying ...

Embodiment 2

[0143] Example 2, Determination of eye barrier permeability of eye guide peptide CC12 and its connecting peptide

[0144] The absorption of foreign substances by the eye has strict selective permeability, and this selection process is mainly realized through the biological barrier of the eye. The blood-retinal barrier is a key biological barrier in the eye, which can selectively regulate the entry of foreign substances into the intraocular tissue, thereby limiting the process of drug delivery from the systemic blood circulation to the posterior segment of the eye. The blood-retinal barrier is composed of an inner barrier and an outer barrier, and its characteristics are similar to those of the blood-brain barrier. Retinal capillary endothelial cells and their connections constitute the inner blood-retinal barrier (iBRB), and retinal pigment epithelium (RPE) and their connections constitute the outer BRB (oBRB).

[0145] Transscleral diffusion delivers drugs to the outer retin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to a peptide with permeable cell membrane or body tissue barrier functions and an application of the peptide. The cell-penetrating peptide can carry functional molecular permeable cell membrane or body tissue barriers and reach a position requiring drug administration, wherein the body tissue barriers are particularly eye barriers. The invention further provides a complex comprising the cell-penetrating peptide and a drug composition comprising the cell-penetrating peptide.

Description

technical field [0001] The invention belongs to the field of biopharmaceuticals, more specifically, the invention relates to a peptide with the function of penetrating cell membrane or body tissue barrier and application thereof. Background technique [0002] At present, neovascular eye diseases such as age-related macular degeneration (AMD) and diabetic retinopathy (DR) have become the main blinding eye diseases, and their prevalence is on the rise. In addition, many posterior segment diseases, such as high myopia, choroidal neovascularization, uveitis, retinal vein occlusion, and cystoid macular edema induced by anterior segment surgery, often seriously damage visual function, bringing great harm to patients, patients' families and society. a huge economic burden. Although laser and surgical treatment can improve or partially preserve the visual function of patients and delay the progression of the disease, the damage to visual function caused by neovascular eye diseases ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/08C12N15/11A61K47/62A61P27/02A61P9/10A61P27/06A61P27/12A61P27/10A61P35/00A61P25/00
CPCA61K9/0019A61K9/0048C07K7/08
Inventor 许迅顾健人陈翀李宗海
Owner SHANGHAI FIRST PEOPLES HOSPITAL